ISPOR Asia Consortium Policies and Procedures
Approved July 15, 2004; Amended May 1, 2006; October 24, 2009; December 7, 2010; December 19, 2011

 

ISPOR Asia Consortium Mission and Objectives

The ISPOR Asia Consortium, a regional group within the organizational structure of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), consists of ISPOR Chapters in Asia as well as individuals interested in the science of pharmacoeconomics (health economics) and outcomes research and its use in health care decisions in Asia, including the use of health technology assessment in the pharmaceutical, biological and medical device and diagnostic arenas. The ISPOR Asia Consortium serves at the discretion of the ISPOR Board of Directors.
The mission of the ISPOR Asia Consortium is consistent with the mission of the Society to advance the science of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical outcomes, economic outcomes, and patient-reported outcomes) in a geographic region, and to facilitate the translation of this research into useful information for health care decision-makers to ensure that scarce health care resources are allocated wisely, fairly, and efficiently. 
The objectives of the ISPOR Asia Consortium are to:

  • Provide an information sharing platform at the regional level for researchers, health care practitioners, and decision-makers interested in pharmacoeconomics (health economics) and outcomes research and members of the pharmaceutical, biological and medical device industry, health care related organizations, and academia;
  • Encourage the use of pharmacoeconomics (health economics) and outcomes research by health care decision-makers in Asia;
  • Promote the concepts of efficiency and affordability for better utilization of health care resources in the different countries in Asia;
  • Provide an opportunity for ISPOR members to become more familiar with pharmacoeconomics and outcomes research as well as health care policies in Asia;
  • Serve as a resource at the regional level for individuals interested in pharmacoeconomics (health economics) and outcomes research; and
  • Promote the formation and support the activities of ISPOR Regional Chapters in Asia.

To fulfill the objectives of the ISPOR Asia Consortium, the Asia Consortium

  • Initiates the planning of ISPOR Asia-Pacific Conferences;
  • Initiates and/or facilitates preparation of articles focusing on pharmacoeconomics (health economics) and outcomes research studies of the populations in Asia for publication in Value in Health Regional Issues, Value & Outcomes Spotlight, or on ISPOR website;
  • Promotes and/or provides quality educational opportunities on pharmacoeconomics (health economics) and outcomes research principles in Asia through programs offered prior to the ISPOR Asia-Pacific Conferences, ISPOR distance learning, and other training activities;
  • Initiates and/or facilitates country or region-based forums, providing direct communication opportunities for different stakeholders including health care researchers, decision-makers, practitioners, and health technology providers;
  • Initiates the development of ISPOR Regional Chapters in Asia and supports ISPOR Regional Chapter activities; and
  • Develops collaborations with related organizations and institutions in Asia.

ISPOR Asia Consortium Membership

Membership of the ISPOR Asia Consortium is open to all individuals who are interested in advancing the science of pharmacoeconomics (health economics) and outcomes research and its use in health care decisions in Asia.

  • Members: all individuals who expressed their interest in joining the ISPOR Asia Consortium and have provided their contact information are accepted as ISPOR Asia Consortium members.
  • Founding Members: members who participated in the initial founding of the ISPOR Asia Consortium are recognized as Founding Members of the Asia Consortium, which includes those who attended the meeting during the ISPOR 1st Asia-Pacific Conference (September 3-5, 2003, Kobe, Japan) or  one of the ISPOR Asia Consortium Founding Member teleconferences (May 10, May 24, and August 31, 2004). Founding Members are acknowledged on the ISPOR Asia Consortium website.

ISPOR Asia Consortium Organizational Structure

The ISPOR Asia Consortium is composed of the Executive Committee, the Advisory Committee, seven Working Committees, and ten Working Subcommittees as follows. The Executive Committee is the governing body. The Advisory Committee is an advisory body to the Executive Committee.
The Working Committees, including Subcommittees, are as follows:

ISPOR Asia Consortium Organizational Structure

ISPOR Asia Consortium Executive Committee

The Asia Consortium Executive Committee is the policy- and decision-making body of the Asia Consortium. The Executive Committee consists of:

  • President of ISPOR Regional Chapters in Asia unless the president appoints a chapter member on behalf of the president;  
  • Chair of the Advisory Committee;
  • Chair of seven Working Committees and Value in Health Regional Issues (ViHRI) Co-Editors-in Chief (Asia);
  • Chair, Chair-elect and immediate Past Chair of the Executive Committee.

The Executive Committee responsibilities are to:

  • Facilitate ISPOR activities in Asia;
  • Select a host country/area where the ISPOR Asia-Pacific Conference will be held, determine the Conference Program Chair(s), and assure that the Conference program meets the needs of the region. The host country/area of the Conference as well as the Conference Chair must be selected at least three years in advance;
  • Recommend ViHRI Co-Editors-in Chief, Co-Editors and Editorial Advisory Board Members (Asia).
  • Oversee Asia Consortium work activities & allocation of any Asia Consortium special funds;
  • Provide suggestions to the ISPOR Board of Directors on health scientific and policy issues important to the region.

The Asia Consortium Executive Committee is led by the Chair. The Asia Consortium Executive Committee Chair and Chair-elect election, term, and responsibilities are as follows:

  • The Chair and Chair-elect must reside in a country in Asia and be a member of ISPOR. All eligible Asia Consortium Executive Committee members can be candidates (except ViHRI Co-Editors-in-Chief per ViHRI Policies and Procedures). All Executive Committee members are eligible to vote. The candidate with the majority votes is the elected Chair-elect. The Chair conducts the election for the Chair-elect. The election of the Chair-elect is in June.
  • Term of the Chair-elect is 2 years, then 2 years as the Chair, and 2 years as the Past Chair. Term of service for a Chair, Chair-elect, and Past Chair is July 1-June 30.
  • Responsibilities of the Chair are to conduct and preside over all meetings of the Executive Committee; represent the Executive Committee when called upon to do so; provide an annual report of Asia Consortium activities to the Board of Directors (in May); and give a welcome speech for the ISPOR Asia-Pacific Conference.
  • Responsibilities of the Chair-elect are to preside over meetings of the Executive Committee in the absence of the Chair; and assist the Chair with the responsibilities of the Executive Committee.

ISPOR Asia Consortium Advisory Committee

The Asia Consortium Advisory Committee is a strategic and technical advisory committee to the Asia Consortium Executive Committee, providing suggestions to the Executive Committee on new initiatives, health science or health policy issues, and other activities of the Asia Consortium.
The Advisory Committee consists of:

  • Past members of the Asia Consortium Advisory Committee;
  • Past members of the Asia Consortium Executive Committee;
  • Past Chairs of the ISPOR Asia-Pacific Conferences;
  • Current and past members of the ISPOR Board of Directors who are residing in Asia;
  • Current and past presidents of ISPOR Regional Chapters in Asia;
  • Asia Consortium members, who are key thought leaders in the discipline and have demonstrated a continuing interest in advancing the science of pharmacoeconomics (health economics) and outcomes research in Asia, as well as have encouraged the use of this science by health care decision-makers in Asia, approved by the Advisory Committee.

The Asia Consortium Advisory Committee is led by the Chair. The Asia Consortium Advisory Committee Chair and Chair-elect election, term, and responsibilities are as follows:

  • The Chair and Chair-elect may or may not reside in a country in Asia, but must be a member of ISPOR. All eligible Asia Consortium Advisory Committee members can be candidates. All Advisory Committee members are eligible to vote. The candidate with the majority votes is the elected Chair-elect. The Chair conducts the election for the Chair-elect. The election of the Chair-elect is in June.
  • Term of the Chair-elect is 2 years, then 2 years as Chair, and 2 years as the Past Chair. Term of service for a Chair, Chair-elect, and Past Chair is July 1-June 30.
  • Responsibilities of the Chair are to conduct and preside over all meetings of the Advisory Committee and to represent the Advisory Committee when called upon to do so;
  • Responsibilities of the Chair-elect are to preside over meetings of the Advisory Committee in the absence of the Chair and to assist the Chair with the responsibilities of the Advisory Committee.

ISPOR Asia-Pacific Conference Program Committee

One of the major activities of the ISPOR Asia Consortium is to initiate and facilitate the ISPOR Asia-Pacific Conferences, which is held every two years in September. The responsibility of the ISPOR Asia-Pacific Conference Program Committee is to develop a scientific program that meets the needs of the region and stimulates thought and debate amongst the delegation, and encourages participation and attendance to the Conference. The ISPOR Asia-Pacific Conference Program Committee consists of the following four subcommittees (Review Committees):

  • ISPOR Asia-Pacific Conference Program Research Review Committee;
  • ISPOR Asia-Pacific Conference Program Health Care Decision-Maker Case Study Review Committee;
  • ISPOR Asia-Pacific Conference Program Workshop Review Committee; and
  • ISPOR Asia-Pacific Conference Program Issue Panel Review Committee.
  • Membership on the ISPOR Asia-Pacific Conference Program Committee is open to all Asia Consortium members who are interested in assisting the development of the Conference program.
  • The ISPOR Asia-Pacific Conference Program Committee Chair(s) is selected by the Asia Consortium Executive Committee. The Chair(s) must reside in the country where the ISPOR Asia-Pacific Conference is held, and be a member of ISPOR. The Chair(s) is responsible for the plenary session topic(s) and speakers and oversight of the ISPOR Asia-Pacific Conference Program Review Committees.
  • The Review Committee Chairs are selected by the Conference Program Committee Chair(s) from the Asia-Pacific Conference Program Committee members or Asia Consortium members – up to two Chairs for each Review Committee – with the approval of the Asia Consortium Executive Committee. The Review Committee Chairs must reside in a country in Asia. The Review Committee Chairs are responsible for the selection of the abstracts/proposals submitted to the Conference for presentations at the Conference. The ISPOR Asia-Pacific Conference Program Chair(s) and the Program Review Committee Chairs meet at least two times via teleconferences during the preparation of the Conference to perform the tasks of the selection of submitted abstracts/proposals, and one time post-Conference to evaluate the performance of the Conference.
  • Term of the service for the Chair(s) is 2 years from October 1-September 30. General responsibilities of the Chair(s) are given below in ISPOR Asia Consortium Committee Chair and Chair-elect Term and Responsibility.
  • ISPOR Asia-Pacific Conference Program Committee Reviewers are approved by the Review Committee Chairs. Reviewers are first invited from the Asia-Pacific Conference Program Committee members, then Asia Consortium members. If more reviewers are needed, the invitation then extends to ISPOR members in and outside of Asia.

ISPOR Asia Consortium Education Committee

The Asia Consortium Education Committee is formed to provide, facilitate, and promote ISPOR educational programs in Asia. Asia Consortium educational activities are conducted through the Short Course Program offered prior to ISPOR Asia-Pacific Conferences, ISPOR Distance Learning Program, or other onsite training programs collaborating with ISPOR Regional Chapters in Asia. The Asia Consortium Education Committee consists of the following two subcommittees:

  • ISPOR Asia-Pacific Conference Short Course Committee; and
  • ISPOR Distance Learning & Onsite Training Committee.
  • Membership on the ISPOR Asia Consortium Education Committee and its subcommittees, unless otherwise indicated, is open to all Asia Consortium members who are interested in promoting education on the science of pharmacoeconomics (health economics) and outcomes research in Asia.
  • The Asia Consortium Education Committee is led by the Chair. The Chair and Chair-elect are selected by the Asia Consortium Executive Committee from the Education Committee members. The Chair and Chair-elect must reside in a country in Asia and be a member of ISPOR. Term and general responsibilities of the Chair and Chair-elect are given below in ISPOR Asia Consortium Committee Chair and Chair-elect Term and Responsibility.

ISPOR Asia-Pacific Conference Short Course Committee

  • The ISPOR Asia-Pacific Conference Short Course Committee is responsible for the development of the Short Course Program for each ISPOR Asia-Pacific Conference, including the selection of short course topics and faculty, and the review of the short course descriptions/syllabi provided by the faculty. Asia Consortium members who reside in Asia are given preference as faculty.
  • The ISPOR Asia-Pacific Conference Short Course Committee Chair and Chair-elect are selected by the Education Committee Chair from the Education Committee members with the approval of the Asia Consortium Executive Committee. The ISPOR Asia-Pacific Conference Short Course Committee Chair and Chair-elect must reside in a country in Asia. Term of service for the Chair and Chair-elect is 2 years from October 1-September 30. General responsibilities are given below in ISPOR Asia Consortium Committee Chair and Chair-elect Term and Responsibility.
  • The ISPOR Asia-Pacific Conference Short Course Committee members are selected by the ISPOR Asia-Pacific Conference Short Course Committee Chair from the Education Committee members with the approval of the Education Committee Chair. The ISPOR Asia-Pacific Conference Short Course Committee members must reside in a country in Asia with at least one member from the country/area that the immediate upcoming ISPOR Asia-Pacific Conference is held. The ISPOR Asia-Pacific Conference Short Course Committee may have up to 8 members, who should represent the diversity of work environments of the Asia Consortium membership. Term of service for all members on the ISPOR Asia-Pacific Conference Short Course Committee is up to 4 years from October 1-September 30, and is evaluated every 2 years (in September).
  • The ISPOR Asia-Pacific Conference Short Course Committee meetings are determined by the tasks for the upcoming ISPOR Asia-Pacific Conference Short Course Program. The ISPOR Asia-Pacific Conference Short Course Committee may hold a joint meeting with the upcoming ISPOR Asia-Pacific Conference Program Committee Chair(s) as determined by the Chairs.

ISPOR Distance Learning & Onsite Training Subcommittee

  • The ISPOR Distance Learning & Onsite Training Committee is responsible for introducing the ISPOR distance learning program in a regional language, and for the development of onsite training programs through collaboration with ISPOR Regional Chapters in Asia.
  • The ISPOR Distance Learning & Onsite Training Committee Chair and Chair-elect are selected by the Education Committee Chair from the Education Committee members with the approval of the Asia Consortium Executive Committee. The Chair and Chair-elect must reside in a country in Asia. Term and general responsibilities are given below in ISPOR Asia Consortium Committee Chair and Chair-elect Term and Responsibility.

ISPOR Asia Consortium Publication Committee

The role of the Asia Consortium Publication Committee is to promote the science of the pharmacoeconomics (health economics) and outcomes research in Asia by translating ISPOR good outcomes research practices, books and other publication into regional languages, and affiliating the preparation of articles for publication in Value in Health, Value in Health Regional Issues and Value & Outcomes Spotlight. The Asia Consortium Publication Committee may act as the Award Committee in the evaluation of research abstracts presented at an ISPOR Asia-Pacific Conference.

  • Membership on the ISPOR Asia Consortium Publication Committee and its subcommittees, unless otherwise indicated, is open to all Asia Consortium members who are interested in promoting the research and publication of the science of pharmacoeconomics (health economics) and outcomes research in Asia.
  • The Asia Consortium Publication Committee is led by the Chair. The Chair and Chair-elect are selected by the Asia Consortium Executive Committee from the Publication Committee members. The Chair and Chair-elect must reside in a country in Asia and be a member of ISPOR. Term and general responsibilities of the Chair and Chair-elect are given below in ISPOR Asia Consortium Committee Chair and Chair-elect Term and Responsibility.

Value in Health Regional Issues Editorial Board (Asia)

Value in Health Regional Issues,an official peer reviewed scientific journal of ISPOR, is initiated to encourage and enhance the science of pharmacoeconomic / health economic and outcomes research and its use in health care decisions in Asia, Latin America, and other regions in the world where the development and use of this science is emerging. Value in Health Regional Issues (ViHRI) includes articles on health care policy analysis, outcomes research (clinical, economic, and patient-reported) empirical studies, methodological studies, and articles on health care resources in the region. ViHRI is managed by the ViHRI Editorial Board.

  • ViHRI Editorial Board consists of the ViHRI Co-Editors-in-Chief and the Co-Editors.
  • The Co-Editors-in-Chief and the Co-Editors of the Editorial Board (Asia) are recommended by the Chair of the Executive Committee and approved by the ISPOR Board of Directors.
  • The Co-Editors-in-Chief are the Co-Chairs of the Editorial Board.

ISPOR Asia Consortium Health Technology Producers (Industry) Committee

The Asia Consortium Health Technology Producers (Industry) Committee is formed to provide a global platform for industry members to discuss issues important to the health technology innovations and market development in Asia. The Asia Consortium Health Technology Producers Committee has the following two subcommittees:

  • Pharmaceuticals & Biologics Committee; and
  • Medical Devices & Diagnostics Committee.
  • Membership on the Asia Consortium Health Technology Producers (Industry) Committee and its subcommittees is open to Asia Consortium members who are from the pharmaceutical, biologic, medical device or diagnostics industry in and outside of Asia.
  • The Asia Consortium Health Technology Producers (Industry) Committee and its subcommittees are led by the Chair. The Chair and Chair-elect are elected positions. The Chair and Chair-elect may or may not reside in a country in Asia. The Chair and Chair-elect of the Asia Consortium Health Technology Producers (Industry) Committee must be a member of ISPOR.
  • All eligible Asia Consortium Health Technology Producers (Industry) Committee members can be candidates. All Health Technology Producers (Industry) Committee members are eligible to vote. The candidate with the majority votes is the elected Chair. The Chair conducts the election for the Chair-elect. The election of the Chair-elect is in June.
  • Term and general responsibilities of the Chair and Chair-elect are given below in ISPOR Asia Consortium Committee Chair and Chair-elect Term and Responsibility.

ISPOR Asia Consortium Health Service Providers (Clinicians) Committee

The Asia Consortium Health Service Providers (Clinicians) Committee is formed to provide a direct communication platform for health care practitioners from different countries in and outside of the region to discuss and debate health technology issues, and share lessons and experience at the clinical level.

  • Membership on the Asia Consortium Health Service Providers (Clinicians) Committee is open to all Asia Consortium members who are health care practitioners, including physicians, pharmacists, nurses, and hospital managers in and outside of Asia.
  • The Asia Consortium Health Service Providers Committee is led by the Chair. The Chair and Chair-elect are elected positions. The Chair and Chair-elect must reside in a country in Asia and be a member of ISPOR.  
  • All eligible Asia Consortium Health Service Providers (Clinicians) Committee members can be candidates. All Health Service Providers (Clinicians) Committee members are eligible to vote. The candidate with the majority votes is the elected Chair. The Chair conducts the election for the Chair-elect. The election of the Chair-elect is in June.
  • Term and general responsibilities of the Chair and Chair-elect are given below in ISPOR Asia Consortium Committee Chair and Chair-elect Term and Responsibility.

ISPOR Asia Consortium Health Technology Assessment Agencies, Health Care Policymakers & Payers Committee

The Asia Consortium Health Technology Assessment Agencies, Health Care Policymakers & Payers Committee is formed to provide a global platform for analysts, researchers, and managers from assessment agencies, government health policymakers, and individuals from public or private health payers to discuss and debate issues related to all health products (including drugs, and medical devices and diagnostics), as well as health policy issues, lessons-learned and experience in health care policy making and implementation.

Membership on the Asia Consortium Health Technology Assessment Agencies, Policymakers & Payers Committee is open to Consortium members who are interested in assessment of health technologies or from a health technology assessment agency, a health care decision making-body and/or a public or private insurance provider organizations in and outside of the region.
The Asia Consortium Health Technology Assessment Agencies, Policymakers & Payers Committee is led by the Chair. The Chair and Chair-elect are elected positions. The Chair and Chair-elect must reside in a country in Asia and must be a member of ISPOR. 

All eligible members of the Asia Consortium Health Technology Assessment Agencies Committee can be candidates. All members of the Health Technology Assessment Agencies, Policymakers & Payers Committee are eligible to vote. The candidate with the majority votes is the Chair. The Chair conducts the election for the Chair-elect. The election of the Chair and Chair-elect is in June.
Term and general responsibilities of the Chair and Chair-elect are given below in ISPOR Asia Consortium Committee Chair and Chair-elect Term and Responsibility.

ISPOR Asia Consortium Committee Chair and Chair-elect Term and Responsibility

  • Term of the ISPOR Asia Consortium committee, working committee, and subcommittee Chair and Chair-elect is 2 years. The Chair-elect then becomes the Chair, and the Chair may then serve 2 years as the Past Chair. Term of service for the Chair, Chair-elect, and Past Chair is July 1-June 30 unless otherwise indicated.
  • The responsibilities of a committee Chair are to conduct and preside over all meetings of the committee; represent the committee when called upon to do so; provide a work plan for the committee annually; and provide an annual report of the committee activities.
  • The responsibilities of the committee Chair-elect are to conduct and preside over all meetings of the committee in the absence of the Chair; and assist the Chair with the responsibilities of the committee.

ISPOR Asia Consortium Operations

  • The ISPOR Asia Consortium is operated mainly through e-mails, teleconferences, or face-to-face meetings. Asia Consortium members are reached at least two times a year via emails to receive the Asia Consortium annual work plan and activity report. All Asia Consortium members are encouraged to join one or more committee(s) of the Asia Consortium and participate in the meetings and other activities initiated by the committee. All committees of the Asia Consortium are led by the committee chair.
  • The Asia Consortium committees, working committees and subcommittees meet at least twice a year via teleconferences or face-to-face meetings at an ISPOR International Meeting, European Congress, or ISPOR Asia-Pacific Conference unless otherwise indicated. The committees, working committees and subcommittees may meet individually or jointly as determined by the committee chairs.
  • Membership on the Asia Consortium committees, working committees and subcommittees is evaluated every year in May (unless otherwise indicated) to assure that all work environments, as well as country perspectives are represented unless otherwise indicated. Members who are inactive (e.g. do not participate in Asia Consortium activities via emails, teleconferences or face-to-face meetings over a 12 month period) will be requested to resign. Term for all committee membership is July 1-June 30 unless otherwise indicated.

Transition of Current ISPOR Asia/Asia-Pacific Organizations to Revised ISPOR Asia Consortium

  • All members on the prior ISPOR Asia Consortium Executive Committee remain members of the Asia Consortium and become members of the new Advisory Committee. The Chair and Chair-elect of the prior Executive Committee are recognized as the Chair and Chair-elect of the new Executive Committee including term of service.
  • All members on the prior ISPOR Asia Consortium Advisory Committee remain members of the Asia Consortium and remain members of the new Advisory Committee. The Chair and Chair-elect of the prior Advisory Committee are recognized as the Chair and Chair-elect of the new Advisory Committee including term of service.
  • The ISPOR Asia-Pacific Medical Device & Diagnostics Council and its Advisory Committee merge into the ISPOR Asia Consortium. All members of this Council and its Advisory Committee become members of the Asia Consortium and new Asia Consortium Advisory Committee.
ISPOR Health Technology Assessment Council in Asia merges into the Asia Consortium. All members in Asia of this Council become members of the Asia Consortium and are encouraged to join the ISPOR Asia Consortium Health Technology Assessment Agencies Committee.To the Top

Back to Asia Consortium main page